0.00
100.00%
-0.9953
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Onconova Therapeutics Inc Borsa (ONTX) Ultime notizie
Who Are The Top Investors In Onconova Therapeutics Inc (NASDAQ:ONTX)? - Yahoo New Zealand News
Yahoo New Zealand News
'Best-In-Class Virology And Oncology': Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Combine to ... - Orrick
Orrick
Onconova Therapeutics' Strategic Acquisition and Corporate Transformation - TipRanks.com - TipRanks
TipRanks
Onconova, Trawsfynydd Therapeutics announces business combination - TipRanks.com - TipRanks
TipRanks
Traws Pharma Announces New Employee Inducement Grants
GlobeNewswire Inc.
Onconova and Trawsfynydd merge to form Traws Pharma - Investing.com South Africa
Investing.com South Africa
We're Keeping An Eye On Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn Rate - Simply Wall St
Simply Wall St
Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024
GlobeNewswire Inc.
Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Benzinga
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket
Benzinga
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace
InvestorPlace
Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s
GlobeNewswire Inc.
Onconova Therapeutics to Present at NobleCon19, Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference
GlobeNewswire Inc.
Zim Doctor Appointed Chief Medical Officer in UK - ZimEye - Zimbabwe News
ZimEye - Zimbabwe News
Onconova doses first patient in trial of cancer combo therapy - Clinical Trials Arena
Clinical Trials Arena
3 Penny Stocks To Buy According To Analysts, Targets Up To 1,029% - Penny Stocks
Penny Stocks
Onconova Therapeutics, Inc. (ONTX) Shares March Higher, Can It Continue? - AOL
AOL
Onconova Therapeutics Appoints Drs. Peter Atadja and Trafford Clarke to its Board of Directors - citybiz
citybiz
Onconova Therapeutics Inc (NASDAQ:ONTX) Doses The First Patient In Phase 2 Clinical Trial At the EB House Austria ... - BP Journal
BP Journal
PrimoHoagies is on a roll, adding 21 stores, while Penn-backed Carisma raises cash to fight cancer - The Philadelphia Inquirer
The Philadelphia Inquirer
45 Stocks Moving in Tuesday's Pre-Market Session - Adial Pharmaceuticals (NASDAQ:ADIL), Arbutus Biopharma - Benzinga
Benzinga
Oncova Therapeutics Inc. (NASDAQ:ONTX) Commence Phase 1 ON 123300 Study In China In Collaborations With ... - BP Journal
BP Journal
Onconova Therapeutics Inc (NASDAQ:ONTX) says the Pivotal Phase 3 INSPIRE trial did not meet its Primary Endpoint - BP Journal
BP Journal
Onconova Therapeutics Inc (NASDAQ:ONTX) Expects To Announce Topline Data Of Inspire Phase 3 Trial Soon: Plans ... - BP Journal
BP Journal
Onconova Therapeutics Inc. (NASDAQ:ONTX) Publishes Phase 1 Oral Rigosertib Combination With Azacitidine Study ... - BP Journal
BP Journal
Onconova Therapeutics Announces $16.5M Share Purchase - GlobeNewswire
GlobeNewswire
People in the News - The Philadelphia Inquirer
The Philadelphia Inquirer
Capitalizzazione:
|
Volume (24 ore):